COMPARISON BETWEEN SUBLINGUAL AND VAGINAL ROUTE OF MISOPROSTOL IN MANAGEMENT OF FIRST TRIMESTER MISCARRIAGE MISSING

Zahra Dehbashi, Mahmood Moosazadeh, Mahdi Afshari, Zahra Dehbashi, Mahmood Moosazadeh, Mahdi Afshari

Abstract

Background: Each year, more than forty million abortions are occurred whole of the world. Misoprostol is a prostaglandin analogue with a strong uterotonic effect. The present study aimed to compare the efficacy of Misoprostol in first trimester abortion through two sublingual and vaginal routes of administration.

Methods: This randomized clinical trial was conducted on 52 consecutive women in first trimester candidate for pregnancy termination because of fetal IUFD or missed abortion in sonography reports. The patients were hospitalized and then randomly assigned to receive sublingual Misoprostol (400 µg, n 27) or vaginal Misoprostol (400 µg placed in posterior fornix, n = 25).

Findings: None of the pregnant in the sublingual group developed complete abortion at the end of follow-up time, while 36% of women inducted with vaginal misoprostol experienced complete abortion indicating a intergroup significant difference (p = 0.001). Compared with vaginal group, those women in sublingual group experienced more complications including diarrhea (22.2% versus 20.0%), nausea and vomiting (22.2% versus 0.0%), and abdominal pain (3.7% versus 0.0%).

Conclusion: The use of Misoprostol in vaginal route results in more abortion completeness as well as lower complication rate as compared to sublingual prescription of the drug.

Keywords: Abortion; Misoprostol; Pregnancy termination; Sublingual; Vaginal route.

Conflict of interest statement

• Conflict of interest: The authors report no conflict of interest related to this paper.

References

    1. Sedgh G, Henshaw SK, Singh S, Bankole A, Drescher J. Legal abortion worldwide: incidence and recent trends. Int Fam Plan Perspect. 2007;33(3):106–16.
    1. Urquhart DR, Templeton AA, Shinewi F, Chapman M, Hawkins K, McGarry J. The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation: UK Multicentre Study - final results. Contraception. 1997;55:1–5.
    1. Blanchard K, Tara Shochet T, Coyajic K, Ngoc N, Winikoff B. Misoprostol alone for early abortion: an evaluation of seven potential regimens. Contraception. 2005;72:91–7.
    1. Costa SH. Commercial availability od misoprostol and induced abortion in Brazil. International Journal of Gynaecology and Obstetrics. 1998;63(Suppl 1):S131–9.
    1. Kapp N, Whyte P, Tang J, Jackson E, Brahmi D. A review of evidence for safe abortion care. Contraception. 2013;88(3):350–63.
    1. Baird DT. Mode of action of medical methods of abortion. J Am Med Womens Assoc. 2000;55(3 Suppl):121–6.
    1. Wong VW, Chan FK. Review: misoprostol or COX-2-specific or selective NSAIDs reduce gastrointestinal complications and symptomatic ulcers. ACP J Club. 2005 May-Jun;142(3):75.
    1. Carbonell JL, Velazco A, Varela L, Cabezas E, Fernandez C, Sanchez C. Misoprostol 3,4, or 5 days after methotrexate for early abortion. Contraception. 1997;56:169–74.
    1. Creinin MD, Vittinghoff E, Galbraith S, Klaisle C. A randomized trial comparing misoprostol three and seven days after methotrexate for early abortion. American Journal of Obstetrics and Gynecology. 1995;173:1578–84.
    1. Vahid Roudsari F, Ayati S, Saghafy N, Shakeri M. Misoprostol alone or in combination with methotrexate for termination of pregnancy at first trimester. Iran J Pharm Res. 2010;9(1):89–94.
    1. Vimala N, Mittal S, Kumar S, Dadhwal V, Sharma Y. A randomized comparison of sublingual and vaginal misoprostol for cervical priming before suction termination of first-trimester pregnancy. Contraception. 2004;70(2):117–20.
    1. Tanha FD, Feizi M, Shariat M. Sublingual versus vaginal misoprostol for the management of missed abortion. J Obstet Gynaecol Res. 2010;36(3):525–32.
    1. Ganguly RP, Saha SP, Mukhopadhyay S, Bhattacharjee N, Bhattacharyya SK, Patra KK. A comparative study on sublingual versus oral and vaginal administration of misoprostol for late first and early second trimester abortion. J Indian Med Assoc. 2010;108(5):283–4.
    1. Saxena P, Sarda N, Salhan S, Nandan D. A randomized comparison between sublingual, oral and vaginal route of misoprostol for pre-abortion cervical ripening in first-trimester pregnancy termination under local anaesthesia. Aust N Z J Obstet Gynaecol. 2008;48(1):101–6.
    1. Fateen B, Rabei N, Mostafa WM. Sublingual versus Vaginal Misoprostol for Preoperative Cervical Priming in First Trimester Missed Abortion. Nat Sci. 2013;11(8):72–7.
    1. Shah N, Azam S, Khan N. Sublingual versus vaginal misoprostol in the management of missed miscarriage. JPMA. 2010;60:113.
    1. Parveen S, Khateeb A, Mufti Z, Shah MA, et al. Comparison of sublingual, vaginal, and oral misoprostol in cervical ripening for first trimester abortion. Indian Journal of Pharmacology. 2011;43(2):172–5.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다